Jul 20, 2026 03:19AM
Jul 18, 2026 02:55PM
Jun 29, 2026 07:05AM
Jun 29, 2026 07:05AM
Jun 25, 2026 06:49AM
Jun 24, 2026 07:05AM
Jun 24, 2026 07:05AM REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
Jun 23, 2026 06:51AM
Jun 22, 2026 10:21AM
Jun 22, 2026 09:50AM
Jun 22, 2026 07:31AM
Jun 22, 2026 07:30AM
Jun 22, 2026 06:43AM
Jun 8, 2026 06:54AM Regenxbio Inc. (RGNX) PT Lowered to $26 at H.C. Wainwright
May 14, 2026 07:10AM
May 14, 2026 07:00AM
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM
Mar 12, 2026 05:14AM
Mar 11, 2026 11:51AM
Mar 11, 2026 11:45AM REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
Mar 10, 2026 09:00AM
Mar 9, 2026 07:46AM
Mar 9, 2026 06:49AM
Mar 6, 2026 04:00PM
Mar 5, 2026 02:11PM
Mar 5, 2026 07:05AM
Mar 3, 2026 09:00AM Shareholders that lost money on REGENXBIO Inc.(RGNX) should contact The Gross Law Firm about pending Class Action - RGNX
Feb 27, 2026 01:10AM
Feb 26, 2026 04:00PM
Feb 26, 2026 11:53AM
Feb 24, 2026 09:00AM
Feb 23, 2026 03:15AM
Feb 20, 2026 04:19AM
Feb 19, 2026 10:15AM The Gross Law Firm Notifies REGENXBIO Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RGNX
Feb 18, 2026 05:00PM
Feb 16, 2026 10:54AM
Feb 11, 2026 06:40AM
Feb 9, 2026 04:05PM
Feb 9, 2026 04:05PM
Jan 29, 2026 06:50AM
Jan 29, 2026 04:44AM Goldman Sachs Reiterates Neutral Rating on Regenxbio Inc. (RGNX)
Jan 29, 2026 04:26AM
Jan 28, 2026 01:51PM
Jan 28, 2026 07:30AM
Jan 28, 2026 07:30AM
Jan 12, 2026 06:53AM
Jan 11, 2026 03:00PM
Dec 19, 2025 07:44AM Regenxbio Inc. (RGNX) PT Raised to $45 at Stifel: Lead Programs Have 2026 Catalysts
Dec 15, 2025 06:20AM

326,362 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All